Patents-Review.com
🔗 Permalink
Assignee profile:

Prosensa Technologies B.V.

City:

Leiden

Country:

Netherlands

Published Applications:

12

Last publication date:

2014-08-07

Patent Grants:

7

Last grant date:

2013-08-27

Top Inventors for applications by Prosensa Technologies B.V.

These are the the leading inventors for applications assigned to Prosensa Technologies B.V.:

Recent patent applications by Prosensa Technologies B.V.

Prosensa Technologies B.V. based in Leiden, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-08-07
US20140221458A1
Chemistry; metallurgy

METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA

 #2 | 2014-05-08
US20140128592A1
Chemistry; metallurgy

METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA

 #3 | 2014-04-24
US20140113955A1
Chemistry; metallurgy

METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA

 #4 | 2012-12-20 ✅ Patent 8,519,097 granted on 2013-08-27
US20120322724A1
Human necessities

Molecules for targeting compounds to various selected organs or tissues

 #5 | 2012-10-11 ✅ Patent 8,802,645 granted on 2014-08-12
US20120259002A1
Chemistry; metallurgy

Molecule for treating an inflammatory disorder

 #6 | 2012-03-08 ✅ Patent 9,139,828 granted on 2015-09-22
US20120059042A1
Chemistry; metallurgy

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

 #7 | 2012-01-26 ✅ Patent 9,926,557 granted on 2018-03-27
US20120022134A1
Chemistry; metallurgy

Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA

 #8 | 2011-12-01 ✅ Patent 9,243,245 granted on 2016-01-26
US20110294753A1
Chemistry; metallurgy

Means and methods for counteracting muscle disorders

 #9 | 2011-10-27
US20110263682A1
Chemistry; metallurgy

METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53

 #10 | 2010-07-22 ✅ Patent 8,268,962 granted on 2012-09-18
US20100184948A1
Human necessities

Molecules for targeting compounds to various selected organs or tissues

 #11 | 2010-07-22 ✅ Patent 8,609,065 granted on 2013-12-17
US20100184947A1
Human necessities

Molecules for targeting compounds to various selected organs, tissues or tumor cells

 #12 | 2009-12-24
US20090318403A1
Human necessities

ANTIBIOTIC COMPOSITION

Also check out Prosensa Technologies B.V.'s (Leiden, Netherlands) applicant profile with 2 patent applications submitted.

AssigneeID:

62612 ⎘